Use of anakinra in severe COVID-19: A case report

Coronavirus disease 19 is a global healthcare emergency with a high lethality rate. Relevant inflammatory cytokine storm is associated with severity of disease, and IL1 inhibition is a cornerstone treatment for hyperinflammatory diseases. We present here the case of a patient with critical COVID-19...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Giovanni Filocamo, Davide Mangioni, Paola Tagliabue, Stefano Aliberti, Giorgio Costantino, Francesca Minoia, Alessandra Bandera
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2020-07-01
Colecção:International Journal of Infectious Diseases
Assuntos:
Anakinra
IL-1
COVID-19
Treatment
Biologic
Acesso em linha:http://www.sciencedirect.com/science/article/pii/S1201971220303337
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados